Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
AT-rich interaction domain 1A | 0.455 | 0.846 | 1.00 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
DNA polymerase gamma, catalytic subunit | 0.457 | 0.846 | 2.1E-09 |
|
disease | 0.110 | None | 1.000 | 0 | 2 | 2007 | 2007 | ||||||||
|
euchromatic histone lysine methyltransferase 1 | 0.460 | 0.808 | 1.00 |
|
disease | 0.100 | None | 0 | 4 | |||||||||||
|
transcription factor 4 | 0.464 | 0.846 | 1.00 |
|
disease | 0.120 | None | 1.000 | 2 | 3 | 2011 | 2014 | ||||||||
|
phospholipase A2 group VI | 0.476 | 0.846 | 2.5E-10 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
mediator complex subunit 12 | 0.476 | 0.769 | 1.00 |
|
disease | 0.100 | None | 0 | 2 | |||||||||||
|
sodium voltage-gated channel alpha subunit 1 | 0.477 | 0.808 | 1.00 |
|
disease | 0.110 | None | 1.000 | 0 | 3 | 2018 | 2018 | ||||||||
|
neurotrophic receptor tyrosine kinase 2 | 0.479 | 0.808 | 1.00 |
|
disease | 0.110 | None | 1.000 | 0 | 1 | 2007 | 2007 | ||||||||
|
ASXL transcriptional regulator 1 | 0.482 | 0.808 | 1.3E-14 |
|
disease | 0.100 | None | 0 | 2 | |||||||||||
|
potassium voltage-gated channel subfamily Q member 1 | 0.485 | 0.769 | 4.5E-08 |
|
disease | 0.110 | None | 1.000 | 0 | 1 | 2018 | 2018 | ||||||||
|
SOS Ras/Rac guanine nucleotide exchange factor 1 | 0.485 | 0.808 | 1.00 |
|
disease | 0.110 | None | 1.000 | 0 | 3 | 2008 | 2008 | ||||||||
|
ryanodine receptor 1 | 0.489 | 0.808 | 1.6E-29 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
calcium voltage-gated channel subunit alpha1 A | 0.489 | 0.769 | 1.00 |
|
disease | 0.130 | None | 1.000 | 0 | 4 | 2015 | 2017 | ||||||||
|
ribosomal protein S6 kinase A3 | 0.491 | 0.846 | 1.00 |
|
disease | 0.100 | None | 0 | 2 | |||||||||||
|
ATPase copper transporting alpha | 0.494 | 0.769 | 1.00 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
SIX homeobox 1 | 0.496 | 0.692 | 0.65 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
glucosylceramidase beta | 0.500 | 0.808 | 1.4E-06 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
stromal interaction molecule 1 | 0.501 | 0.808 | 0.78 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
AT-rich interaction domain 1B | 0.503 | 0.846 | 1.00 |
|
disease | 0.120 | None | 1.000 | 2 | 4 | 2012 | 2019 | ||||||||
|
SATB homeobox 2 | 0.503 | 0.769 | 1.00 |
|
disease | 0.120 | None | 1.000 | 0 | 2 | 2017 | 2018 | ||||||||
|
platelet activating factor acetylhydrolase 1b regulatory subunit 1 | 0.504 | 0.769 | 1.00 |
|
disease | 0.140 | None | 1.000 | 3 | 1 | 1999 | 2012 | ||||||||
|
MKS transition zone complex subunit 1 | 0.505 | 0.769 | 3.4E-16 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
nuclear receptor binding SET domain protein 1 | 0.505 | 0.769 | 1.00 |
|
disease | 0.140 | None | 1.000 | 0 | 1 | 2009 | 2017 | ||||||||
|
occludin | 0.507 | 0.846 | 8.6E-07 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
solute carrier family 26 member 4 | 0.507 | 0.885 | 9.0E-22 |
|
disease | 0.100 | None | 0 | 2 |